| 1 |
Garvanovic SH, Taniguchi AH, Kim UR, Mascetti CR. Case Report: Perioperative Management of Combined Coronary Artery Bypass Grafting, Liver and Kidney Transplantation in a Patient With Antiphospholipid Syndrome. Transplant Direct 2021;7:e756. [PMID: 34514111 DOI: 10.1097/TXD.0000000000001214] [Reference Citation Analysis]
|
| 2 |
Garg N, Rennke HG, Pavlakis M, Zandi-Nejad K. De novo thrombotic microangiopathy after kidney transplantation. Transplant Rev (Orlando). 2018;32:58-68. [PMID: 29157988 DOI: 10.1016/j.trre.2017.10.001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 3 |
Bacchetta J, Cochat P. Primary disease recurrence—effects on paediatric renal transplantation outcomes. Nat Rev Nephrol 2015;11:371-84. [PMID: 25917555 DOI: 10.1038/nrneph.2015.54] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 4 |
Abbas F, El Kossi M, Kim JJ, Sharma A, Halawa A. Thrombotic microangiopathy after renal transplantation: Current insights in de novo and recurrent disease. World J Transplantation 2018; 8(5): 122-141 [PMID: 30211021 DOI: 10.5500/wjt.v8.i5.122] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 5 |
Furmańczyk-Zawiska A, Bączkowska T, Dęborska-Materkowska D, Nazarewski S, Kosieradzki M, Durlik M. Effect of Thrombophilic Factors on Renal Graft Function: A Single-Center Experience. Transplant Proc 2018;50:1715-9. [PMID: 30056888 DOI: 10.1016/j.transproceed.2018.02.096] [Reference Citation Analysis]
|
| 6 |
Parajuli S, Lockridge JB, Langewisch ED, Norman DJ, Kujovich JL. Hypercoagulability in Kidney Transplant Recipients. Transplantation. 2016;100:719-726. [PMID: 26413991 DOI: 10.1097/tp.0000000000000887] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Choi JY, Jung JH, Shin S, Kim YH, Han DJ. Living donor renal transplantation in patients with antiphospholipid syndrome: A case report. Medicine (Baltimore) 2016;95:e5419. [PMID: 27861383 DOI: 10.1097/MD.0000000000005419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 8 |
Tsuchimoto A, Matsukuma Y, Ueki K, Nishiki T, Doi A, Okabe Y, Nakamura M, Tsuruya K, Nakano T, Kitazono T, Masutani K. Thrombotic microangiopathy associated with anticardiolipin antibody in a kidney transplant recipient with polycythemia. CEN Case Rep. 2019;8:1-7. [PMID: 30073489 DOI: 10.1007/s13730-018-0354-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 9 |
Gracia-Tello B, Isenberg D. Kidney disease in primary anti-phospholipid antibody syndrome. Rheumatology (Oxford) 2017;56:1069-80. [PMID: 27550302 DOI: 10.1093/rheumatology/kew307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 10 |
Salvadori M, Tsalouchos A. Therapeutic apheresis in kidney transplantation: An updated review. World J Transplant 2019; 9(6): 103-122 [PMID: 31750088 DOI: 10.5500/wjt.v9.i6.103] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Espinosa G, Cervera R. Current treatment of antiphospholipid syndrome: lights and shadows. Nat Rev Rheumatol 2015;11:586-96. [PMID: 26122952 DOI: 10.1038/nrrheum.2015.88] [Cited by in Crossref: 79] [Cited by in F6Publishing: 60] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 12 |
Fernando MH, Jayarajah U, Rubakan D, Fonseka R, Goonewardena S. Complete necrosis of graft ureter following renal transplant in a patient with primary antiphospholipid syndrome: A case report. Clin Case Rep 2018;6:1330-3. [PMID: 29988620 DOI: 10.1002/ccr3.1620] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
